EthOss is a UK-founded dental med-tech business operating at the intersection of regenerative biomaterials and clinical dentistry.
EthOss supplies regenerative bone grafting materials for use in dentistry and oral surgery. Developed by clinicians in the UK, EthOss® Bone Graft is a fully synthetic solution proven to help patients grow back their own bone with no graft particles left behind. EthOss is supplied into over 60 countries through an international network of distributors.
Sentio acted for the shareholders including founders Peter Fairbairn and Paul Harrison and their families. Managing Director Peter Wheeler will continue to lead the team alongside Sales Director Joe Harrison. The acquirer’s decentralised structure ensures the continuity of operations at the company’s base in Silsden, West Yorkshire, from where it will continue to develop market share and access new strategic international territories, supported by ongoing clinical innovation and product development.
Lifco Group are a Nasdaq Stockholm listed acquirer of market-leading niche businesses. A long-term owner of businesses, Lifco is focused on delivering sustainable growth in earnings and cashflows and growing its portfolio by acquisition. The companies in Lifco’s Dental business area are leading suppliers of consumables, equipment and technical service to dentists across Europe, backing specialist dental med-tech platforms for long-term growth. Overall group net sales were €26.1 million in 2025 and EBITA was €5.9 million.
EthOss Regeneration Managing Director Peter Wheeler commented:
“We are pleased to be announcing Lifco’s majority investment into EthOss and look forward to continuing to develop the EthOss brand across our international markets. As long-term investors the Lifco deal provides stability and opportunity for all our stakeholders, including customers, suppliers and staff. The founders and management remain significant shareholders in the business, providing continuity and reflecting their continued confidence in the future.”
Sentio Partners’ Brooke Fenton, Will Arnold and Dave Irwin acted as lead advisors to the shareholders.
Commenting on the transaction Will Arnold, partner, said:
“It has been a pleasure working with the EthOss team to secure a majority sale of the business, crystallising value now whilst offering the potential for significant future upside. EthOss has developed a fantastic product supported by a brand that resonates with both patients and clinicians. As a high-growth dental med-tech business, EthOss is at an inflexion point in its international growth journey and is looking forward to further success under Lifco’s ownership.”
The Sentio team worked alongside Glaisyers (Niki Polymeridou, Julian Bond, Niamh Howarth, Ryan Baratzi) as legal advisor with Azets (Simon Roberts) providing tax advice. Walker Morris (Holly ter Bruggen, Oliver Duke, Brenna Varcoe) and BDO (Stephen Allender, Nick Millward) advised Lifco.
